US 7276629
Hydrogenation of imine intermediates of sertraline with catalysts
granted A61PA61P25/24
Quick answer
US patent 7276629 (Hydrogenation of imine intermediates of sertraline with catalysts) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61P, A61P25/24